Inflammation: Depression fans the flames and feasts on the heat

American Journal of Psychiatry

Volumn 172, Issue 11, 2015, Pages 1075-1091

  Kiecolt Glaser, Janice K ^a   Derry, Heather M ^a   Fagundes, Christopher P ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CELECOXIB; CORTICOTROPIN RELEASING FACTOR; ESCITALOPRAM; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORTRIPTYLINE; OMEGA 3 FATTY ACID; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ALCOHOLISM; COGNITIVE THERAPY; DEPRESSION; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXERCISE; FATIGUE; GENE EXPRESSION PROFILING; HEALTH BEHAVIOR; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIFE STRESS; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; OBESITY; PATHOGENESIS; PERSONAL EXPERIENCE; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; SLEEP DISORDER; CHILDHOOD TRAUMA SURVIVOR; DYSBIOSIS; IMMUNOLOGY; INTESTINE; MENTAL STRESS; METABOLISM; PERMEABILITY; PSYCHOLOGY;

ADULT SURVIVORS OF CHILD ADVERSE EVENTS; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HEALTH BEHAVIOR; HUMANS; INFLAMMATION; INTESTINES; OBESITY; PERMEABILITY; STRESS, PSYCHOLOGICAL;

EID: 84946152121     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15020152     Document Type: Review

References (200)

1. Shelton RC, Miller AH: Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 2010;91:275-299
2. Slavich GM, Irwin MR: From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 2014;140:774-815
3. Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. PsychosomMed 2009;71:171-186
4. Dowlati Y, Herrmann N, Swardfager W, et al: A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457
5. Liu Y, Ho RC, Mak A: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-a), and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a metaanalysis and meta-regression. J Affect Disord 2012;139:230-239
6. Valkanova V, Ebmeier KP, Allan CL: CRP, IL-6, and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013;150:736-744
7. Copeland WE, Shanahan L, Worthman C, et al: Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012;71:15-21
8. Matthews KA, Schott LL, Bromberger JT, et al: Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav Immun 2010;24:96-101
9. Deverts DJ, Cohen S, Di Lillo VG, et al: Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Developmentin Young Adults (CARDIA) study. Psychosom Med 2010;72:734-741
10. Duivis HE, De Jonge P, Penninx BW, et al: Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospectivefindingsfrom the heartand soul study. Am J Psychiatry 2011;168:913-920
11. Kim JW, Szigethy EM, Melhem NM, et al: Inflammatory markers and the pathogenesis of pediatric depression and suicide: a systematic review of the literature. J Clin Psychiatry 2014;75:1242-1253
12. Khandaker GM, Pearson RM, Zammit S, et al: Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 2014;71:1121-1128
13. Rethorst CD, Bernstein I, Trivedi MH: Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES). J Clin Psychiatry 2014;75:e1428-e1432
14. Raison CL, Miller AH: Is depression an inflammatory disorder? Curr Psychiatry Rep 2011;13:467-475
15. Glassman AH, Miller GE: Where there is depression, there is inflammation... sometimes! Biol Psychiatry 2007;62:280-281
16. Haroon E, Raison CL, Miller AH: Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012;37:137-162
17. Raison CL, Rutherford RE, Woolwine BJ, et al: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013;70:31-41
18. Rapaport MH, Nierenberg AA, Schettler PJ, et al: Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry (Epub ahead of print, March 24, 2014)
19. Miller AH, Haroon E, Raison CL, et al: Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 2013;30:297-306
20. Irwin MR, Cole SW: Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011;11:625-632
21. Capuron L, Miller AH: Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011;130:226-238
22. Dantzer R, O'Connor JC, Lawson MA, et al: Inflammationassociated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011;36:426-436
23. Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation, and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012;36:764-785
24. Eyre H, Baune BT: Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012;37:1397-1416
25. Stetler C, Miller GE: Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011;73:114-126
26. Pace TWW, Hu F, Miller AH: Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007;21:9-19
27. Conway-Campbell BL, Pooley JR, Hager GL, et al: Molecular dynamics of ultradian glucocorticoid receptor action. Mol Cell Endocrinol 2012;348:383-393
28. Zunszain PA, Anacker C, Cattaneo A, et al: Glucocorticoids, cytokines, and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:722-729
29. Dantzer R, O'Connor JC, Freund GG, et al: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56
30. Suri D, Vaidya VA: Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 2013;239:196-213
31. Tata DA, Anderson BJ: The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers, and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiol Behav 2010;99:186-193
32. Anacker C, Cattaneo A, Luoni A, et al: Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 2013;38:872-883
33. Raison CL, Miller AH: Malaise, melancholia, and madness: the evolutionary legacy of an inflammatory bias. Brain Behav Immun 2013;31:1-8
34. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31
35. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-741
36. Berk M, Williams LJ, Jacka FN, et al: So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200
37. Della Gioia N, Hannestad J: A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev 2010;34:130-143
38. Bull SJ, Huezo-Diaz P, Binder EB, et al: Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 2009;14:1095-1104
39. Udina M, Moreno-España J, Navinés R, et al: Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 2013;38:1803-1813
40. Udina M, Castellví P, Moreno-España J, et al: Interferon-induced depression in chronic hepatitis C: a systematic review and metaanalysis. J Clin Psychiatry 2012;73:1128-1138
41. Eller T, Vasar V, Shlik J, et al: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:445-450
42. Su KP, Lai HC, Yang HT, et al: Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry 2014;76:559-566
43. O'Brien SM, Scully P, Fitzgerald P, et al: Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 2007;41:326-331
44. Carvalho LA, Torre JP, Papadopoulos AS, et al: Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord 2013;148:136-140
45. Yoshimura R, Hori H, Ikenouchi-Sugita A, et al: Higher plasma interleukin-6 (IL-6) level is associatedwithSSRI-orSNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:722-726
46. Baune BT, Dannlowski U, Domschke K, et al: The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 2010;67:543-549
47. Vogelzangs N, Comijs HC, Oude Voshaar RC, et al: Late-lifedepression symptomprofiles are differentially associated with immunometabolic functioning. Brain Behav Immun 2014;41:109-115
48. Hodes GE, Pfau ML, Leboeuf M, et al: Individual differences in the peripheralimmunesystem promote resilience versus susceptibility to social stress. Proc Natl Acad Sci USA 2014;111:16136-16141
49. Yu YW, Chen TJ, Hong CJ, et al: Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003;28:1182-1185
50. Cattaneo A, Gennarelli M, Uher R, et al: Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline "predictors" and longitudinal "targets". Neuropsychopharmacology 2013;38:377-385
51. Wong ML, Dong C, Maestre-Mesa J, et al: Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry 2008;13:800-812
52. Mayer EA, Knight R, Mazmanian SK, et al: Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 2014;34:15490-15496
53. Cryan JF, Dinan TG: Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701-712
54. Maes M, Kubera M, Leunis JC: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol Lett 2008;29:117-124
55. Kéri S, Szabó C, Kelemen O: Expression of Toll-like receptors in peripheral blood mononuclear cells and response to cognitivebehavioral therapy in major depressive disorder. Brain Behav Immun 2014;40:235-243
56. Leclercq S, Matamoros S, Cani PD, et al: Intestinal permeability, gut-bacterialdysbiosis, andbehavioralmarkersof alcohol-dependence severity. Proc Natl Acad Sci USA 2014;111:E4485-E4493
57. Dinan TG, Stanton C, Cryan JF: Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74:720-726
58. Ait-Belgnaoui A, Durand H, Cartier C, et al: Prevention of gut leakinessbya probiotic treatment leads to attenuatedHPAresponse to an acute psychological stress in rats. Psychoneuroendocrinology 2012;37:1885-1895
59. Nanni V, Uher R, Danese A: Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry 2012;169:141-151
60. Danese A, Moffitt TE, Pariante CM, et al: Elevated inflammation levels in depressed adults with a history of childhoodmaltreatment. Arch Gen Psychiatry 2008;65:409-415
61. Kiecolt-Glaser JK, Gouin JP, Weng NP, et al: Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med 2011;73:16-22
62. Miller GE, Chen E, Parker KJ: Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a modelof behavioraland biological mechanisms. Psychol Bull 2011;137:959-997
63. Fagundes CP, Glaser R, Kiecolt-Glaser JK: Stressful early life experiences and immune dysregulation across the lifespan. Brain Behav Immun 2013;27:8-12
64. Tursich M, Neufeld RW, Frewen PA, et al: Association of trauma exposure with proinflammatory activity: a transdiagnostic metaanalysis. Transl Psychiatry 2014;4:e413
65. Heim C, Newport DJ, Mletzko T, et al: The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008;33:693-710
66. Carpenter LL, Gawuga CE, Tyrka AR, et al: Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 2010;35:2617-2623
67. Gouin JP, Glaser R, Malarkey WB, et al: Childhood abuse and inflammatoryresponses to daily stressors. Ann Behav Med 2012;44:287-292
68. Huijbregts KML, Van Der Feltz-Cornelis CM, Van Marwijk HWJ, et al: Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review. J Psychosom Res 2010;68:511-519
69. Griffis CA, Crabb Breen E, Compton P, et al: Acute painful stressand inflammatory mediator production. Neuroimmunomodulation 2013;20:127-133
70. Zhou D, Kusnecov AW, Shurin MR, et al: Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993;133:2523-2530
71. Benson S, Kattoor J, Wegner A, et al: Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012;153:794-799
72. Watkins LR, Maier SF: Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005;257:139-155
73. Fishbain DA, Cole B, Lewis JE, et al: Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review. Pain Med 2014;15:1522-1539
74. Gerrits MM, Van Oppen P, Leone SS, et al: Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders. BMC Psychiatry 2014;14:187
75. Irwin MR: Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol 2015;66:143-172
76. Lopresti AL, Hood SD, Drummond PD: A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep, and exercise. J Affect Disord 2013;148:12-27
77. Raison CL, Rye DB, Woolwine BJ, et al: Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 2010;68:942-949
78. Cho HJ, Seeman TE, Kiefe CI, et al: Sleep disturbance and longitudinal risk of inflammation: moderating influences of social integration and social isolation in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Brain Behav Immun 2015;46:319-326
79. Irwin MR, Olmstead R, Carrillo C, et al: Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 2012;35:537-543
80. Rahe C, Unrath M, Berger K: Dietary patterns and the risk of depression in adults: a systematic review of observational studies. Eur J Nutr 2014;53:997-1013
81. Lai JS, Hiles S, Bisquera A, et al: A systematic review and metaanalysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr 2014;99:181-197
82. Sánchez-Villegas A, Delgado-Rodríguez M, Alonso A, et al: Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch Gen Psychiatry 2009;66:1090-1098
83. Rienks J, Dobson AJ, Mishra GD: Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: results from a large community-based prospective study. Eur J Clin Nutr 2013;67:75-82
84. Esposito K, Marfella R, Ciotola M, et al: Effect of a Mediterraneanstyle diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292:1440-1446
85. Dai J, Miller AH, Bremner JD, et al: Adherence to the Mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation 2008;117:169-175
86. Milaneschi Y, Bandinelli S, Penninx BW, et al: Depressive symptoms and inflammation increase in a prospective study of older adults: a protective effect of a healthy (Mediterranean-style) diet. Mol Psychiatry 2011;16:589-590
87. Lucas M, Chocano-Bedoya P, Shulze MB, et al: Inflammatory dietary pattern and risk of depression among women. Brain Behav Immun 2014;36:46-53
88. Fontana L: Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol 2009;44:41-45
89. Lutter M, Krishnan V, Russo SJ, et al: Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 2008;28:3071-3075
90. Aksungar FB, Topkaya AE, Akyildiz M: Interleukin-6, C-reactive protein, and biochemical parameters during prolonged intermittent fasting. Ann Nutr Metab 2007;51:88-95
91. Chaix A, Zarrinpar A, Miu P, et al: Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 2014;20:991-1005
92. Inoue W, Somay G, Poole S, et al: Immune-to-brain signaling and central prostaglandin E2 synthesis in fasted rats with altered lipopolysaccharide-inducedfever. Am J Physiol Regul Integr Comp Physiol 2008;295:R133-R143
93. Fond G, Macgregor A, Leboyer M, et al: Fasting in mood disorders: neurobiology and effectiveness: a review of the literature. Psychiatry Res 2013;209:253-258
94. Maes M, Berk M, Goehler L, et al: Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012;10:66
95. Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010;68:140-147
96. Giles GE, Mahoney CR, Kanarek RB: Omega-3 fatty acids influence mood in healthy and depressed individuals. Nutr Rev 2013;71:727-741
97. Appleton KM, Rogers PJ, Ness AR: Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010;91:757-770
98. Bloch MH, Hannestad J: Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 2012;17:1272-1282
99. Grosso G, Pajak A, Marventano S, et al: Role of omega-3fatty acids in the treatment of depressive disorders: a comprehensive metaanalysis of randomized clinical trials. PLoS One 2014;9:e96905
100. Sublette ME, Ellis SP, Geant AL, et al: Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011;72:1577-1584
101. Martins JG: EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009;28:525-542
102. Sijben JWC, Calder PC: Differentialimmunomodulation with longchain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007;66:237-259
103. Ariel A, Serhan CN: Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007;28:176-183
104. Ferrucci L, Cherubini A, Bandinelli S, et al: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006;91:439-446
105. Farzaneh-Far R, Harris WS, Garg S, et al: Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 2009;205:538-543
106. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al: Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010;411:584-591
107. Rangel-Huerta OD, Aguilera CM, Mesa MD, et al: Omega-3 longchain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 2012;107(Suppl 2):S159-S170
108. Kiecolt-Glaser JK, Belury MA, Andridge R, et al: Omega-3 supplementation lowers inflammation in healthymiddle-aged andolder adults: a randomized controlled trial. Brain Behav Immun 2012;26:988-995
109. Su KP, Huang SY, Peng CY, et al: Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 2010;67:550-557
110. Carlezon WAJ Jr, Mague SD, Parow AM, et al: Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005;57:343-350
111. Pittet YK, Berger MM, Pluess TT, et al: Blunting the response to endotoxin in healthy subjects: effects of various doses of intravenous fish oil. Intensive Care Med 2010;36:289-295
112. Pluess TT, Hayoz D, Berger MM, et al: Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007;33:789-797
113. Song C, Li X, Leonard BE, et al: Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res 2003;44:1984-1991
114. Azevedo Da Silva M, Singh-Manoux A, Brunner EJ, et al: Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur J Epidemiol 2012;27:537-546
115. Mammen G, Faulkner G: Physical activity and the prevention of depression: a systematic review of prospective studies. Am J Prev Med 2013;45:649-657
116. Lancaster GI, Febbraio MA: The immunomodulating role of exercise in metabolic disease. Trends Immunol 2014;35:262-269
117. Gleeson M, Bishop NC, Stensel DJ, et al: The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;11:607-615
118. Trivedi MH, Greer TL, Church TS, et al: Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry 2011;72:677-684
119. Rethorst CD, Toups MS, Greer TL, et al: Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry 2013;18:1119-1124
120. Nicklas BJ, Brinkley TE: Exercise training as a treatment for chronic inflammation in the elderly. Exerc Sport Sci Rev 2009;37:165-170
121. Calder PC, Ahluwalia N, Brouns F, et al: Dietary factors and lowgrade inflammation in relation to overweight and obesity. Br J Nutr 2011;106(Suppl 3):S5-S78
122. Beavers KM, Brinkley TE, Nicklas BJ: Effect of exercise training on chronic inflammation. Clin Chim Acta 2010;411:785-793
123. Luppino FS, De Wit LM, Bouvy PF, et al: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67:220-229
124. Kyrou I, Chrousos GP, Tsigos C: Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006;1083:77-110
125. Räikkönen K, Matthews KA, Kuller LH: Depressive symptoms and stressful life events predict metabolic syndrome among middleaged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007;30:872-877
126. Brydon L, Wright CE, O'Donnell K, et al: Stress-induced cytokine responses and central adiposity in young women. Int J Obes 2008;32:443-450
127. McInnis CM, Thoma MV, Gianferante D, et al: Measures of adiposity predict interleukin-6 responses to repeated psychosocial stress. Brain Behav Immun 2014;42:33-40
128. Franceschi C, Bonafè M, Valensin S, et al: Inflamm-aging: an evolutionary perspective on immunosenescence. AnnNY Acad Sci 2000;908:244-254
129. Mirsoian A, Bouchlaka MN, Sckisel GD, et al: Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med 2014;211:2373-2383
130. Hammen C: Generation of stress in the course of unipolar depression. J Abnorm Psychol 1991;100:555-561
131. Husky M, Mazure C, Maciejewski P, et al: Past depression and gender interact to influence emotional reactivity to daily life stress. Cognit Ther Res 2009;33:264-271
132. O'Grady MA, Tennen H, Armeli S: Depression history, depression vulnerability, and the experience of everyday negative events. J Soc Clin Psychol 2010;29:949-974
133. Herr NR, Hammen C, Brennan PA: Current and past depression as predictors of family functioning: a comparison of men and women in a community sample. J Fam Psychol 2007;21:694-702
134. Kiecolt-Glaser JK, Jaremka L, Andridge R, et al: Marital discord, past depression, and metabolic responses to high-fat meals: interpersonal pathways to obesity. Psychoneuroendocrinology 2015;52:239-250
135. Johnson JD, O'Connor KA, Deak T, et al: Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun 2002;16:461-476
136. Dantzer R, Wollman E, Vitkovic L, et al: Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999;4:328-332
137. Erridge C: The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr 2011;105:15-23
138. Herieka M, Erridge C: High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014;58:136-146
139. Moreira A PB, Texeira TFS, Ferreira AB, et al: Influence of a high-fat diet on gut microbiota, intestinal permeability, and metabolic endotoxaemia. Br J Nutr 2012;108:801-809
140. Willette AA, Lubach GR, Coe CL: Environmental context differentially affects behavioral, leukocyte, cortisol, and interleukin-6 responses to low doses of endotoxin in the rhesus monkey. Brain Behav Immun 2007;21:807-815
141. Anisman H, Merali Z, Poulter MO, et al: Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 2005;11:963-972
142. Dietz DM, Laplant Q, Watts EL, et al: Paternal transmission of stress-induced pathologies. Biol Psychiatry 2011;70:408-414
143. Shanks N, Lightman SL: The maternal-neonatal neuro-immune interface: are there long-term implications for inflammatory or stress-related disease? J Clin Invest 2001;108:1567-1573
144. McDade TW, Hoke M, Borja JB, et al: Do environments in infancy moderate the association between stress and inflammation in adulthood? Initial evidence from a birth cohort in the Philippines. Brain Behav Immun 2013;31:23-30
145. Glaser R, Robles TF, Sheridan J, et al: Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003;60:1009-1014
146. Christian LM, Franco A, Iams JD, et al: Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women. Brain Behav Immun 2010;24:49-53
147. Maes M, Ombelet W, De Jongh R, et al: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 2001;63:85-92
148. Pace TWW, Mletzko TC, Alagbe O, et al: Increased stress-induced inflammatoryresponses in malepatients withmajor depressionand increased early life stress. Am J Psychiatry 2006;163:1630-1633
149. Weinstein AA, Deuster PA, Francis JL, et al: Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol Psychol 2010;84:228-234
150. Fagundes CP, Glaser R, Hwang BS, et al: Depressive symptoms enhance stress-induced inflammatory responses. Brain Behav Immun 2013;31:172-176
151. Von Känel R, Kudielka BM, Preckel D, et al: Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun 2006;20:40-48
152. Köhler O, Benros ME, Nordentoft M, et al: Effect of antiinflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014;71:1381-1391
153. Uher R, Tansey KE, Dew T, et al: An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. AmJ Psychiatry 2014;171:1278-1286
154. Miller GE, Chen E, Sze J, et al: A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NFkappaB signaling. Biol Psychiatry 2008;64:266-272
155. Franceschi C: Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev 2007;65:S173-S176
156. Vogelzangs N, Kritchevsky SB, Beekman ATF, et al: Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 2008;65:1386-1393
157. Alexopoulos GS, Morimoto SS: The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry 2011;26:1109-1118
158. Danese A, Moffitt TE, Harrington H, et al: Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 2009;163:1135-1143
159. Penninx BWJH, Milaneschi Y, Lamers F, et al: Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013;11:129
160. Vogelzangs N, Beekman ATF, Van Reedt Dortland AK, et al: Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 2014;39:1624-1634
161. Choi J, Joseph L, Pilote L: Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013;14:232-244
162. Irwin MR, Wang M, Ribeiro D, et al: Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 2008;64:538-540
163. Grandner MA, Buxton OM, Jackson N, et al: Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 2013;36:769-779E
164. Lopez-Garcia E, Schulze MB, Fung TT, et al: Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004;80:1029-1035
165. Kasapis C, Thompson PD: The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005;45:1563-1569
166. Jaremka LM, Fagundes CP, Glaser R, et al: Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation. Psychoneuroendocrinology 2013;38:1310-1317
167. Valentine RJ, Woods JA, McAuley E, et al: The associations of adiposity, physical activity, and inflammation with fatigue in older adults. Brain Behav Immun 2011;25:1482-1490
168. Wegner A, Elsenbruch S, Maluck J, et al: Inflammation-induced hyperalgesia: effects of timing, dosage, and negative affect on somatic pain sensitivity in human experimental endotoxemia. Brain Behav Immun 2014;41:46-54
169. Levitzky YS, Guo CY, Rong J, et al: Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis 2008;201:217-224
170. O'Connor MF, Bower JE, Cho HJ, et al: To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 2009;23:887-897
171. Yang Y, Kozloski M: Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci 2011;66:493-500
172. Moieni M, Irwin MR, Jevtic I, et al: Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 2015;40:1709-1716
173. Lamers F, Vogelzangs N, Merikangas KR, et al: Evidence for a differential role of HPA-axis function, inflammation, and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 2013;18:692-699
174. Ueland T, Gullestad L, Nymo SH, et al: Inflammatory cytokines as biomarkers in heart failure. Clin Chim Acta 2015;443:71-77
175. Miller AH, Raison CL: Are anti-inflammatory therapies viable treatments for psychiatric disorders? Where the rubber meets the road. JAMA Psychiatry 2015;72:527-528
176. Tyring S, Gottlieb A, Papp K, et al: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006;367:29-35
177. Langley RG, Feldman SR, Han C, et al: Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol 2010;63:457-465
178. Monk JP, Phillips G, Waite R, et al: Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 2006;24:1852-1859
179. Persoons P, Vermeire S, Demyttenaere K, et al: The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther 2005;22:101-110
180. Selvin E, Paynter NP, Erlinger TP: The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007;167:31-39
181. Kiecolt-Glaser JK, Christian L, Preston H, et al: Stress, inflammation, and yoga practice. Psychosom Med 2010;72:113-121
182. Kiecolt-Glaser JK, Bennett JM, Andridge R, et al: Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol 2014;32:1040-1049
183. Kox M, Van Eijk LT, Zwaag J, et al: Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc Natl Acad Sci USA 2014;111:7379-7384
184. Bower JE, Greendale G, Crosswell AD, et al: Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology 2014;43:20-29
185. Irwin MR, Olmstead R, Carrillo C, et al: Cognitive behavioral therapy vs tai chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep 2014;37:1543-1552
186. Vitiello MV, McCurry SM, Shortreed SM, et al: Short-term improvement in insomnia symptoms predicts long-term improvements in sleep, pain, and fatigue in older adults with comorbid osteoarthritis and insomnia. Pain 2014;155:1547-1554
187. Miller GE, Brody GH, Yu T, et al: A family-oriented psychosocial intervention reduces inflammation in low-SES African American youth. Proc Natl Acad Sci USA 2014;111:11287-11292
188. Gazal M, Souza LD, Fucolo BA, et al: The impact of cognitive behavioral therapy on IL-6 levels in unmedicated women experiencing the first episode of depression: a pilot study. Psychiatry Res 2013;209:742-745
189. Chen H-Y, Cheng IC, Pan Y-J, et al: Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. Kidney Int 2011;80:415-422
190. Zautra AJ, Davis MC, Reich JW, et al: Comparison of cognitive behavioraland mindfulness meditationinterventions onadaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 2008;76:408-421
191. Hannestad J, Della Gioia N, Bloch M: The effect of antidepressantmedication treatment on serum levels of inflammatory cytokines: ameta-analysis. Neuropsychopharmacology 2011;36:2452-2459
192. Leclercq S, De Saeger C, Delzenne N, et al: Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol Psychiatry 2014;76:725-733
193. Manber R, Edinger JD, Gress JL, et al: Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008;31:489-495
194. Ehde DM, Dillworth TM, Turner JA: Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol 2014;69:153-166
195. Bower JE, Ganz PA, Aziz N, et al: Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 2007;21:251-258
196. Jaremka LM, Fagundes CP, Peng J, et al: Loneliness promotes inflammation during acute stress. Psychol Sci 2013;24:1089-1097
197. Derry HM, Fagundes CP, Andridge R, et al: Lower subjective social status exaggerates interleukin-6 responses to a laboratory stressor. Psychoneuroendocrinology 2013;38:2676-2685
198. Bennett JM, Glaser R, Andridge RR, et al: Long lasting effects of smoking: breast cancer survivors' inflammatory responses to acute stress differ by smoking history. Psychoneuroendocrinology 2013;38:179-187
199. Kiecolt-Glaser JK, Loving TJ, Stowell JR, et al: Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry 2005;62:1377-1384
200. Cuijpers P, Vogelzangs N, Twisk J, et al: Comprehensive metaanalysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 2014;171:453-462